H.C. Wainwright lowered the firm’s price target on Citius Pharmaceuticals (CTXR) to $4 from $100 and keeps a Buy rating on the shares following ...

President Trump’s threatened tariffs could lead to higher out-of-pocket costs or insurance premiums, depending on whether ...

The US president vows "major" tariffs on imported medicines - raising fears of an increase in costs for Americans.

Recursion Pharmaceuticals, a trailblazing TechBio company, has made a significant stride in the realm of oncology by dosing the first patient in its Phase 1 clinical trial for a potential B-cell ...

Conduit Pharmaceuticals (CDT) announces the filing of two groundbreaking patents for tapinarof, VTAMA, including a dual active cocrystal, ...

在科技飞速进步的今天，人工智能（AI）正在悄然改变各个领域，尤其是在医药研发方面。最近，Recursion Pharmaceuticals（RXRX.US）等AI医药开发概念股的股价大幅上涨，吸引了投资者的目光。根据智通财经APP的报道，Recursion Pharmaceuticals的股价上涨近23%，而Certara（CERT.US）和Simulations Plus（SLP.US）也分别上 ...

Trump said he would announce pharmaceutical tariffs, as he increased tariffs on China to 125% and paused tariffs for 75 ...

Trump predicted a tariff on foreign pharmaceuticals will prompt drug companies to move their operations to the United States.

Former President Donald Trump announced a major new tariff on pharmaceutical imports to encourage drug manufacturers to ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $478.12, a high ...

Analysts' ratings for Alnylam Pharmaceuticals ALNY over the last quarter vary from bullish to bearish, as provided by 27 ...

Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit" or the “Company”) today announced that its Board of Directors has authorized a share repurchase program under which the Company may purchase up to ...